Selective CB2 Agonist JWH-133 Suppresses Viability and Migration-Related Responses in Prostate Cancer Cells
Pharmaceuticals · 19.07.2026 · 19 (7) · 1114
DOI: 10.3390/ph19071114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 19.07.2026. Verfasst von Seda Sabah Özcan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Manisa Celal Bayar University, Manisa 4500, Türkiye. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Department of Scientific Research Projects, Yozgat Bozok University Scientific Research Projects.
Abstract (Originalsprache)
Background/Objectives: Cannabinoid receptor type 2 (CB2) agonists have attracted attention because of their potential effects on tumor-related cellular processes in different cancer models. In the present study, we investigated the effects of the selective CB2 agonist JWH-133 on prostate cancer cell lines (LNCaP, DU-145, and PC3).
Methods
Cell viability was evaluated using the MTT assay, while colony-forming capacity and migration-related responses were assessed by colony formation and wound-healing assays, respectively. In addition, the expression levels of selected cell-cycle- and apoptosis-related genes were analyzed by quantitative real-time PCR.
Results
JWH-133 reduced cell viability in a time- and concentration-dependent manner, although the magnitude of this effect differed among prostate cancer cell lines. The compound also reduced colony formation in PC3 and LNCaP cells and decreased wound closure in PC3 cells under the experimental conditions used. Furthermore, JWH-133 altered the expression of several cell-cycle- and apoptosis-related genes in DU-145 and PC3 cells.
Conclusions
Overall, these findings suggest that JWH-133 modulates multiple cellular responses in prostate cancer cells in a cell-line-dependent manner. However, additional mechanistic studies are required to clarify the molecular pathways underlying these effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Biology, Faculty of Medicine, Manisa Celal Bayar University, Manisa 4500, Türkiye.
- Department of Medical Biology, Faculty of Medicine, İzmir Bakırçay University, Izmir 35660, Türkiye.
- Department of Physiology, Faculty of Medicine, Yozgat Bozok University, Yozgat 66200, Türkiye.
ORCID-Profile: Rehime Yapar, İsmail Değerli, Murat Çakır
Förderung
- the Department of Scientific Research Projects
- Yozgat Bozok University Scientific Research Projects
Zitieren
APA
Özcan, S. S., Yapar, R., Değerli, İ., Elmas, L., Korkmaz, M., & Çakır, M. (2026). Selective CB2 Agonist JWH-133 Suppresses Viability and Migration-Related Responses in Prostate Cancer Cells. Pharmaceuticals, 19(7), 1114. https://doi.org/10.3390/ph19071114
Vancouver
Özcan SS, Yapar R, Değerli İ, Elmas L, Korkmaz M, Çakır M. Selective CB2 Agonist JWH-133 Suppresses Viability and Migration-Related Responses in Prostate Cancer Cells. Pharmaceuticals. 2026;19(7):1114. doi:10.3390/ph19071114
BibTeX
@article{zcan2026,
author = {Özcan, Seda Sabah and Yapar, Rehime and Değerli, İsmail and Elmas, Levent and Korkmaz, Mehmet and Çakır, Murat},
title = {Selective CB2 Agonist JWH-133 Suppresses Viability and Migration-Related Responses in Prostate Cancer Cells},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {7},
pages = {1114},
doi = {10.3390/ph19071114}
}
EUVIMED